Call on ‘generics drugs only’ clause after internal talks, says govt

New Delhi : Union health minister Mansukh Mandaviya held a meeting on Monday to discuss contentious issues related to the newly notified regulations by the National Medical Council (NMC). The minister said he will take an ‘appropriate decision’ after internal discussions, people in the know told ET.

The Indian Medical Association (IMA) has vehemently opposed the National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, which mandate doctors to prescribe only generic drugs. The other contentious issue discussed during the meeting was medical conferences in five-star hotels with cocktail dinners. The NMC has barred doctors from participating in seminars, workshops, or conferences that “involve direct or indirect sponsorships from pharma companies or the allied health sector”.

“The meeting went very well. It lasted two hours as the minister gave the opportunity to everyone. We have presented what the medical fraternity feels. The government will take a decision later on the issues,” said Dr Sharad Agarwal, national president, IMA. The meeting was attended by IMA officials, drug lobby group Indian Pharmaceutical Alliance (IPA), officials from the ministry, and the NMC.

Related Posts

Annovis Bio receives US patent covering new crystalline form of buntanetap

Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

The enforcement wing of Karnataka’s Food Safety and Drugs Control Department has seized medical devices and consumables worth ₹13.79 lakh from two establishments in Bengaluru’s Cottonpet area for alleged violations…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Annovis Bio receives US patent covering new crystalline form of buntanetap

Annovis Bio receives US patent covering new crystalline form of buntanetap

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels